PhenomeX Inc. Common Stock
CELL
CELL was delisted on the 29th of September, 2023.
57 hedge funds and large institutions have $35.8M invested in PhenomeX Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 40 closing their positions.
62% more capital invested
Capital invested by funds: $22.1M → $35.8M (+$13.7M)
32% less funds holding
Funds holding: 84 → 57 (-27)
44% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 18
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
68% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 40
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$7.53M |
| 2 |
TAM
Terrapin Asset Management
Miami,
Florida
|
+$1.62M |
| 3 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
+$1.3M |
| 4 |
CM
Crystalline Management
Montreal, Quebec,
Canada
|
+$920K |
| 5 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
+$487K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NV
Northpond Ventures
Bethesda,
Maryland
|
-$2.64M |
| 2 |
MAM
Monaco Asset Management
Monaco
|
-$2.6M |
| 3 |
NIMC
Nierenberg Investment Management Company
Camas,
Washington
|
-$2.43M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$1.09M |
| 5 |
BlackRock
New York
|
-$679K |
CELL Hedge Fund Activity: Q3 2023 in Review
57 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in PhenomeX Inc. Common Stock (CELL) for Q3 2023, worth a combined $35.8M — up 62% from $22.1M a quarter earlier.
Sellers outnumbered buyers: 40 funds closed out of CELL and 13 opened new positions — a net loss of 27 holders — while 18 trimmed existing stakes and 10 added.
The largest buyer was Beryl Capital Management, opening a new position worth an estimated $7.53M. The largest seller was Northpond Ventures, exiting entirely with an estimated $2.64M sold.
- 57 institutional investors held PhenomeX Inc. Common Stock (CELL) as of Q3 2023, down from 84 in Q2 2023.
- Funds reported $35.8M of PhenomeX Inc. Common Stock stock for Q3 2023, up 62% quarter-over-quarter.
- 13 funds opened new PhenomeX Inc. Common Stock positions in Q3 2023 and 40 closed out, a net change of -27 holders.
- The largest PhenomeX Inc. Common Stock buyer in Q3 2023 was Beryl Capital Management, an estimated $7.53M added.
- The largest PhenomeX Inc. Common Stock seller in Q3 2023 was Northpond Ventures, an estimated $2.64M sold.
Based on aggregated 13F filings for Q3 2023.